Clinical Trial Update: Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating azithromycin for patients with chronic rhinosinusitis who have failed medical and surgical therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Chronic Rhinosinusitis, High-risk Patient | Phase 4 | Status: COMPLETED